PRJNA264871
Changes in gut microbial diversity in response to olanzapine treatment
This study aims to identify changes in relative abundance of gut-resident commensal microbiota in response to treatment with the second-generation antipsychotic drug olanzapine. Olanzapine is known to induce weight gain in human patients and mouse models. We aim to provide a link between its effects on the gut microbiome and body composition.